DMAC vs ZION · $157.4M cap vs P/E 11, rev $354.0M
DiaMedica Therapeutics Inc (DMAC) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
DMAC currently screens at market cap $157.4M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the DMAC and ZION stock pages for the full models.
Not investment advice.